Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

R. Landewé, J. Braun, A. Deodhar, M. Dougados, W. P. Maksymowych, P. J. Mease, J. D. Reveille, M. Rudwaleit, D. Van Der Heijde, C. Stach, B. Hoepken, A. Fichtner, G. Coteur, M. De Longueville, J. Sieper

Research output: Contribution to journalArticlepeer-review

257 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds